| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer | Chief Scientific Officer
1 company
Eilon D. Kirson last filed a Form 4 in February 2019, as Chief Science Officer at NVCR. Eilon D. Kirson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 152,408 shares of NVCR. The NVCR filings lean toward selling, a net 834,249 shares.
Eilon D. Kirson has 22 Form 4 filings on record from December 2016 to February 2019, all as Chief Science Officer at NovoCure (NVCR), 2016–2019.
The 42 reported transactions were 19 open-market sales, 13 option exercises, 4 option or other derivative awards and 4 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 11 sales worth about $24.3M.
The largest open-market sale was 346,161 shares of NVCR at an average $28.90 on June 4, 2018, about $10.0M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2019 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 168,813 | $45.17 | $7,624,788.25 | -60.8% | |
| Jun 4, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 346,161 | $28.90 | $10,003,513.78 | -89.7% | |
| Apr 18, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 147,825 | $24.00 | $3,547,800.00 | -78.9% | |
| Jan 11, 2018 | NVCR Novocure Ltd | Chief Science Officer | Sell | 25,320 | $22.00 | $557,126.09 | -88.8% | |
| Nov 6, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 9,100 | $22.00 | $200,200.00 | -24.2% | |
| Nov 3, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 3,400 | $22.00 | $74,800.00 | -8.3% | |
| Nov 1, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 22,269 | $22.01 | $490,110.44 | -35.2% | |
| Jun 21, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 66,361 | $16.78 | $1,113,205.78 | -23.0% | |
| Jun 19, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 15,000 | $15.06 | $225,885.00 | -4.9% | |
| Jun 13, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 9,044 | $15.01 | $135,768.53 | -2.9% |